| An algorithm for the grading of activity in chronic hepatitis C P Bedossa, T Poynard Hepatology 24 (2), 289-293, 1996 | 5125 | 1996 |
| Natural history of liver fibrosis progression in patients with chronic hepatitis C T Poynard, P Bedossa, P Opolon The Lancet 349 (9055), 825-832, 1997 | 4160 | 1997 |
| Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis … T Poynard, P Marcellin, SS Lee, C Niederau, GS Minuk, G Ideo, V Bain, ... The Lancet 352 (9138), 1426-1432, 1998 | 3162 | 1998 |
| Sampling variability of liver biopsy in nonalcoholic fatty liver disease V Ratziu, F Charlotte, A Heurtier, S Gombert, P Giral, E Bruckert, ... Gastroenterology 128 (7), 1898-1906, 2005 | 2378 | 2005 |
| Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study F Imbert-Bismut, V Ratziu, L Pieroni, F Charlotte, Y Benhamou, T Poynard The Lancet 357 (9262), 1069-1075, 2001 | 1969 | 2001 |
| Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients Y Benhamou, M Bochet, V Di Martino, F Charlotte, F Azria, A Coutellier, ... Hepatology 30 (4), 1054-1058, 1999 | 1624 | 1999 |
| Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C T Poynard, J McHutchison, M Manns, C Trepo, K Lindsay, Z Goodman, ... Gastroenterology 122 (5), 1303-1313, 2002 | 1492 | 2002 |
| Liver fibrosis in overweight patients V Ratziu, P Giral, F Charlotte, E Bruckert, V Thibault, I Theodorou, L Khalil, ... Gastroenterology 118 (6), 1117-1123, 2000 | 1349 | 2000 |
| Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C JG McHutchison, M Manns, K Patel, T Poynard, KL Lindsay, C Trepo, ... Gastroenterology 123 (4), 1061-1069, 2002 | 1329 | 2002 |
| Viral hepatitis C T Poynard, MF Yuen, V Ratzin, CL Lai The Lancet 362 (9401), 2095-2100, 2003 | 1307 | 2003 |
| Viral hepatitis B CL Lai, V Ratziu, MF Yuen, T Poynard The Lancet 362 (9401), 2089-2094, 2003 | 1280 | 2003 |
| Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression GL Davis, MJ Alter, H El–Serag, T Poynard, LW Jennings Gastroenterology 138 (2), 513-521. e6, 2010 | 1160 | 2010 |
| Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients With Gastrointestinal Bleeding: A Meta–Analysis B Bernard, JD Grangé, EN Khac, X Amiot, P Opolon, T Poynard Hepatology 29 (6), 1655-1661, 1999 | 1079 | 1999 |
| Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C T Poynard, V Ratziu, F Charlotte, Z Goodman, J McHutchison, J Albrecht Journal of hepatology 34 (5), 730-739, 2001 | 1014 | 2001 |
| Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus AJ Thompson, AJ Muir, MS Sulkowski, D Ge, J Fellay, KV Shianna, ... Gastroenterology 139 (1), 120-129. e18, 2010 | 970 | 2010 |
| Extrahepatic manifestations of chronic hepatitis C P Cacoub, T Poynard, P Ghillani, F Charlotte, M Olivi, J Charles Piette, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 943 | 1999 |
| Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography M Friedrich-Rust, K Wunder, S Kriener, F Sotoudeh, S Richter, J Bojunga, ... Radiology 252 (2), 595-604, 2009 | 911 | 2009 |
| Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration T Poynard, V Leroy, M Cohard, T Thevenot, P Mathurin, P Opolon, ... Hepatology 24 (4), 778-789, 1996 | 896 | 1996 |
| Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C T Poynard, V Ratziu, J McHutchison, M Manns, Z Goodman, S Zeuzem, ... Hepatology 38 (1), 75-85, 2003 | 790 | 2003 |
| Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial V Ratziu, P Giral, S Jacqueminet, F Charlotte, A Hartemann–Heurtier, ... Gastroenterology 135 (1), 100-110, 2008 | 780 | 2008 |
